X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1207) 1207
Paper (689) 689
Publication (363) 363
Report (196) 196
Book Review (16) 16
Dissertation (2) 2
Book / eBook (1) 1
Book Chapter (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
experiment (743) 743
physics (708) 708
high energy physics - experiment (660) 660
particle physics (655) 655
cern lhc coll (623) 623
experimental results (615) 615
physics - high energy physics - experiment (582) 582
cms (544) 544
high energy physics (473) 473
p p: scattering (443) 443
p p: colliding beams (394) 394
physics of elementary particles and fields (370) 370
phenomenology (305) 305
13000 gev-cms (272) 272
particle physics - experiment (257) 257
nuclear experiment (235) 235
scattering [p p] (234) 234
hep (226) 226
8000 gev-cms (212) 212
hadron-hadron scattering (205) 205
colliding beams [p p] (190) 190
background (168) 168
physics, particles & fields (128) 128
supersymmetry (112) 112
transverse momentum: missing-energy (96) 96
elementary particles, quantum field theory (90) 90
quantum field theories, string theory (90) 90
cern lab (87) 87
channel cross section: upper limit (86) 86
final state:jet lepton (83) 83
astrophysics (82) 82
quantum physics (79) 79
classical and quantum gravitation, relativity theory (78) 78
instrumentation and detectors (78) 78
high energy astrophysical phenomena (76) 76
transverse momentum dependence (76) 76
mass dependence (75) 75
astronomy & astrophysics (69) 69
index medicus (69) 69
rapidity dependence (69) 69
nuclear physics (67) 67
kinematics (66) 66
bottom: particle identification (64) 64
data analysis method (62) 62
jet: bottom (62) 62
top: pair production (61) 61
z0: leptonic decay (57) 57
transverse momentum (55) 55
collisions (52) 52
physics and astronomy (52) 52
humans (51) 51
hep-ex (50) 50
channel cross section: branching ratio: upper limit (49) 49
higgs particle: hadroproduction (49) 49
quantum chromodynamics: perturbation theory (49) 49
muon: pair production (48) 48
physics, nuclear (48) 48
7000 gev-cms (47) 47
differential cross section: measured (47) 47
jet: transverse momentum (47) 47
channel cross section: measured (46) 46
lead (46) 46
beyond standard model (45) 45
final state:jet dilepton (45) 45
new physics: search for (45) 45
nuclear and high energy physics (45) 45
physical sciences (44) 44
rapidity (44) 44
electroweak interaction (43) 43
science & technology (43) 43
luminosity (42) 42
mass spectrum: (42) 42
gravitation (41) 41
pharmacology & pharmacy (41) 41
w: leptonic decay (41) 41
squark: pair production (40) 40
jet: multiplicity (39) 39
final state:jet (38) 38
large hadron collider (38) 38
bottom: pair production (37) 37
mass: lower limit (37) 37
nuclear & particles physics (37) 37
jet lepton (36) 36
narrow resonance (36) 36
searching (35) 35
sensitivity (35) 35
decay (34) 34
pair production [top] (34) 34
higher-order: 1 (33) 33
phase space (33) 33
structure (33) 33
dijet (32) 32
física (32) 32
higgs particle: hadronic decay (32) 32
missing-energy [transverse momentum] (32) 32
z0: associated production (32) 32
nuclear physics - experiment (31) 31
upper limit [channel cross section] (31) 31
114 physical sciences (30) 30
higgs physics (30) 30
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Biomaterials, ISSN 0142-9612, 2006, Volume 27, Issue 28, pp. 4831 - 4839
Journal Article
Recent Patents on Drug Delivery and Formulation, ISSN 1872-2113, 09/2011, Volume 5, Issue 3, pp. 214 - 226
Traditional drug delivery systems are not efficient for peptide, protein and nucleic acid (plasmid DNA, oligonucleotides or short interfering RNA) delivery,... 
Proteins | Peptides | DNA | siRNA | Nanostructure lipid carriers | Gene therapy | Lipid drug conjugates | Solid lipid nanoparticles | Adjuvants
Journal Article
Expert Opinion on Therapeutic Patents, ISSN 1354-3776, 05/2008, Volume 18, Issue 5, pp. 515 - 524
Background: Cationic lipids have been among the more efficient synthetic gene delivery reagents in vitro. They condense nucleic acids into cationic particles... 
gene therapy | siRNA | cationic lipids | DNA | non-viral vectors | Non-viral vectors | Gene therapy | Cationic lipids
Journal Article
Trends in Biotechnology, ISSN 0167-7799, 12/2004, Volume 22, Issue 12, p. 612
  Type 1 diabetes affects an estimated 150 million people worldwide and results from an autoimmune-mediated destruction of insulin-producing β-cells. In the... 
Rodents | Stem cells | Pancreas | Insulin
Journal Article
Trends in Biotechnology, ISSN 0167-7799, 03/2003, Volume 21, Issue 3, p. 109
  Much interest and effort has focused on the therapeutic potential of stem cell technology to treat presently intractable diseases. However, this scientific... 
Studies | Medical research | Ethics | Human rights | Transplants & implants | Cloning | Stem cells | Arthritis | Bans | Embryos
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 02/2005, Volume 45, Issue 2, pp. 168 - 176
The pharmacokinetics of piperacillin/tazobactam (4 g/0.5 g every 6 or 8 hours, by 20-minute intravenous infusion) were studied in 14 patients with acute renal... 
Appropriate antimicrobial therapy | Tazobactam | Continuous venovenous hemofiltration (CWH) | Piperacillin | Sepsis | Pharmacokinetics | Peritonitis | continuous venovenous hemofiltration (CVVH) | peritonitis | tazobactam | AMIKACIN | SINGLE-DOSE PHARMACOKINETICS | FAILURE | appropriate antimicrobial therapy | pharmacokinetics | REPLACEMENT THERAPY | SEPTIC SHOCK | HEMODIALYSIS | PHARMACOLOGY & PHARMACY | piperacillin | CRITICALLY-ILL PATIENTS | sepsis | TRAUMA PATIENTS | HEMODIAFILTRATION | Kidney - physiology | Chromatography, High Pressure Liquid - methods | Piperacillin - blood | Area Under Curve | Humans | Middle Aged | Half-Life | Piperacillin - pharmacokinetics | Male | Piperacillin - administration & dosage | Inpatients | Time Factors | Female | Drug Therapy, Combination | Penicillanic Acid - analogs & derivatives | Penicillanic Acid - administration & dosage | Kidney Failure, Chronic - physiopathology | Intensive Care Units | Kidney - drug effects | Kidney Failure, Chronic - diagnosis | Kidney Failure, Chronic - drug therapy | Penicillanic Acid - pharmacokinetics | Critical Care | Aged | Hemofiltration - methods | Microbial Sensitivity Tests - methods | Penicillanic Acid - blood | Complications and side effects | Filtration | Dosage and administration | Research | Drug therapy | Health aspects | Blood | Index Medicus
Journal Article
Journal Article
Enfermedades Infecciosas y Microbiología Clínica, ISSN 0213-005X, 2009, Volume 29, Issue 3, pp. 167 - 173
Abstract Introduction Acute otitis media is the most common respiratory tract infection in infancy and early childhood that is managed with antimicrobial... 
Infectious Disease | Amoxicilina | Niños | Acute otitis media | Amoxicillin | Ceftriaxona | Children | Ceftriaxone | Haemophilus influenzae | Streptococcus pneumoniae | Otitis media aguda | MIDDLE-EAR FLUID | INFECTIOUS DISEASES | ANTIBIOTICS | CLINICAL EFFICACY | PENETRATION | MICROBIOLOGY | PHARMACODYNAMICS | PHARMACOKINETICS | SELECTION | Pneumococcal Infections - drug therapy | Ceftriaxone - blood | beta-Lactam Resistance | Haemophilus influenzae - drug effects | Humans | Ceftriaxone - pharmacology | Amoxicillin-Potassium Clavulanate Combination - pharmacology | Dose-Response Relationship, Drug | Microbial Sensitivity Tests | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Streptococcus pneumoniae - isolation & purification | Computer Simulation | Haemophilus influenzae - enzymology | Pneumococcal Infections - microbiology | Child | Haemophilus Infections - drug therapy | Streptococcus pneumoniae - drug effects | Otitis Media - drug therapy | Amoxicillin - blood | Amoxicillin - pharmacokinetics | Haemophilus influenzae - isolation & purification | Ceftriaxone - pharmacokinetics | Amoxicillin-Potassium Clavulanate Combination - blood | Ceftriaxone - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - pharmacokinetics | Amoxicillin - pharmacology | Amoxicillin - therapeutic use | Haemophilus Infections - microbiology | Monte Carlo Method | Streptococcus pneumoniae - enzymology
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2005, Volume 27, Issue 9, pp. 1444 - 1451
Journal Article